{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-003844","form_type":"8-K","ticker":null,"cik":"0001289047","company_name":"AI Technology Group Inc.","filed_at":"2026-06-12T21:05:43+00:00","discovered_at":"2026-06-12T21:08:00.293222+00:00","generated_at":"2026-06-12T21:11:02.108402+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"AI Tech Group amends merger agreement; extends closing to Dec 31, 2026, sets $50M minimum raise","bullets":["Second amendment to merger with AVM Biotechnology and Biomed 360 details investment tranches: $1M (Tranche 1), $1.125M (partial Tranche 2), plus $500K monthly from June to Oct 2026 and $375K in Nov.","Tranche 2 loans are convertible at $2.50/share with 10% simple interest; closing extended to Dec 31, 2026 (extendable to Mar 31, 2027).","Tranche 3 requires at least $50M in gross proceeds before closing, at $5.00/share or higher, with a senior US exchange up‑listing.","All other terms of the original Merger Agreement remain unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-003844","json":"https://secwatch.observer/filing/0001477932-26-003844.json","markdown":"https://secwatch.observer/filing/0001477932-26-003844.md","text":"https://secwatch.observer/filing/0001477932-26-003844.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1289047/000147793226003844/0001477932-26-003844-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1289047/000147793226003844/aipg_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T21:11:02.108402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f88ecae2bcc7a7a4fdcde109588e4fcd25c9011c","claim":"AI Technology Group Inc. entered into Agreement and Plan of Merger with AVM Biotechnology Inc. , a Nevada corporation (“AVM”), and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”) (effective 2025-09-15).","evidence_excerpt":"On September 15, 2025, AI Technology Group Inc. (the “Corporation”) filed, as Exhibit 10 to its registration statement filed on Form 10-12G, entered into a Agreement and Plan of Merger with AVM Biotechnology Inc. , a Nevada corporation (“AVM”), and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289047/000147793226003844/0001477932-26-003844-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"AVM Biotechnology Inc. , a Nevada corporation (“AVM”), and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”)"},{"label":"Effective","value":"2025-09-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}